Seyed Soheil Saeedi Saravi

Harvard Medical School

Dr. Seyed Soheil Saeedi Saravi, PharmD, PhD, senior scientist at Harvard Medical School, received his PhD in 2016 from Tehran University of Medical Sciences (TUMS), followed by a post doc at Harvard Medical School. His research areas include cardiovascular biology and aging, atherosclerosis, and redox biology. He has authored of over 55 peer-reviewed publications, edited 8 books and chapters, and presented at over 30 international conferences. He has served as editorial board and reviewer of >20 prestigious journals, e.g. European Heart Journal, and professional member of over 10 international scientific associations, including American Heart Association (AHA), European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). He has been honored with numerous international and national awards (25 prizes), namely, including \"Paul Dudley White International Award\" from American Heart Association, \"AGLA Walter Riesen Award\" from Swiss Atherosclerosis Association, prize of \"European Atherosclerosis Society Young Investigator Fellowship 2021\", and \"Harvard Postdoctoral Fellowship\".

Seyed Soheil Saeedi Saravi

1books edited

2chapters authored

Latest work with IntechOpen by Seyed Soheil Saeedi Saravi

Nitric Oxide Synthase - Simple Enzyme-Complex Roles provides information on nitric oxide synthase, a biomolecule of key importance for the different biological systems, including central and peripheral nervous, cardiovascular, and reproductive systems. With recent links to the role of nitric oxide in the reactions that can impact cell signaling, and discoveries surrounding the complex role of nitric oxide synthase that have increased research attention across the fields of cell and molecular biology, physiology, pharmacology, toxicology, neuroscience, cardiology, urology, and endocrinology, this book tries to provide a comprehensive overview of biology/pathobiology of nitric oxide synthases and a perspective from possible therapeutic indication of the enzyme inhibitors.

Go to the book